Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and the Brussels-based Oncidium foundation today announce that results for the NOBLE Registry of TLX599-CDx (99m Tc-iPSMA) ...

The company develops new medicines which targets the orphan diseases in the field of cardiology, oncology, neurology and inflammation. The company is also involved in manufacturing Positron Emission ...

Pulmonary angiography, specifically the computed tomographic version, is the gold standard for diagnosing lung embolism.

Australian specialists, scientists and researchers are at the forefront of treatments that could change the lives of people ...